BiocardiaInc Total Assets from 2010 to 2024

BCDA Stock  USD 0.42  0.01  2.44%   
BiocardiaInc's Total Assets are increasing over the years with very volatile fluctuation. Total Assets are expected to dwindle to about 9.3 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
1996-09-30
Previous Quarter
6.4 M
Current Value
3.7 M
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BiocardiaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BiocardiaInc main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.6 K, Interest Expense of 6.6 K or Selling General Administrative of 3.3 M, as well as many exotic indicators such as Price To Sales Ratio of 23.42, Dividend Yield of 0.0182 or Operating Cycle of 58.08. BiocardiaInc financial statements analysis is a perfect complement when working with BiocardiaInc Valuation or Volatility modules.
  
This module can also supplement BiocardiaInc's financial leverage analysis and stock options assessment as well as various BiocardiaInc Technical models . Check out the analysis of BiocardiaInc Correlation against competitors.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.

Latest BiocardiaInc's Total Assets Growth Pattern

Below is the plot of the Total Assets of BiocardiaInc over the last few years. Total assets refers to the total amount of BiocardiaInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BiocardiaInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. BiocardiaInc's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BiocardiaInc's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 9.79 M10 Years Trend
Very volatile
   Total Assets   
       Timeline  

BiocardiaInc Total Assets Regression Statistics

Arithmetic Mean12,528,720
Geometric Mean10,597,745
Coefficient Of Variation44.82
Mean Deviation3,971,669
Median13,328,000
Standard Deviation5,615,305
Sample Variance31.5T
Range22.5M
R-Value0.11
Mean Square Error33.6T
R-Squared0.01
Significance0.71
Slope133,078
Total Sum of Squares441.4T

BiocardiaInc Total Assets History

20249.3 M
202311.3 M
20229.8 M
202115.7 M
202023.4 M
20197.7 M
20186.4 M

About BiocardiaInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include BiocardiaInc income statement, its balance sheet, and the statement of cash flows. BiocardiaInc investors use historical funamental indicators, such as BiocardiaInc's Total Assets, to determine how well the company is positioned to perform in the future. Although BiocardiaInc investors may use each financial statement separately, they are all related. The changes in BiocardiaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BiocardiaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BiocardiaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BiocardiaInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Total Assets11.3 M9.3 M

Pair Trading with BiocardiaInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with BiocardiaInc Stock

  0.77MBRX Moleculin Biotech Upward RallyPairCorr
  0.79MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against BiocardiaInc Stock

  0.82DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.74MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.72MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.65MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.62EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BiocardiaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BiocardiaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardiainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardiainc Stock:
Check out the analysis of BiocardiaInc Correlation against competitors.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for BiocardiaInc Stock analysis

When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stocks Directory
Find actively traded stocks across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.028
Quarterly Revenue Growth
0.684
Return On Assets
(1.22)
Return On Equity
(7.29)
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.